COVID-19 Vaccine: 2 TSX Stocks to Watch

With a potential COVID-19 vaccine in the development pipeline, investors are feeling more positive about the stock market. These are two stocks to watch!

| More on:
healthcare pharma

Image source: Getty Images

Earlier today, American pharmaceutical giant Pfizer announced its COVID-19 vaccine candidate was showing 90% effectiveness in trials. While there’s more testing to be done, this is unquestionably positive news for people everywhere.

While there’s still a ways to go between now and the potential distribution of a vaccine, there’s now some light at the end of the tunnel. So, naturally, this positive sentiment has made its way to the stock market.

With COVID-19 vaccine news in tow, the stock market as a whole has rebounded in a major way. With investors more confident in the economy going forward, many stocks have been taking off.

Today, we’ll look at two TSX stocks Canadian investors can keep an eye on following this important announcement.

Enbridge

Enbridge (TSX:ENB)(NYSE:ENB) is a major Canadian energy distribution company. While the stock has struggled recently, it’s due for a turnaround.

If the economy starts to open up even more with a COVID-19 vaccine, Enbridge is in line to benefit. After all, without much action in the economy there has been much less demand for energy.

Enbridge had a great start to 2020 before being derailed by the pandemic. It traded as high as $57.13 in February and is trading at $37.52 as of this writing.

So, even though it’s been experiencing a near-5% jump today, it still has a long ways to go to even get back to previous levels. With a stronger economy surrounding it, Enbridge could be a prime rebound candidate.

As for its dividend, the payout ratio of 329% certainly isn’t encouraging. It’s possible Enbridge has to cut its dividend sooner than later, but a speedy recovery would go a long way in quelling those fears.

If you’re looking to pick up a solid blue-chip TSX stock with rebound potential in light of a COVID-19 vaccine, Enbridge is a solid choice.

Air Canada

Air Canada (TSX:AC) is Canada’s largest airline and as such has been in a peculiar position as of late. Its stock has been down around 70% on the year at various points recently.

Of course, some tighter new restrictions haven’t helped the case for Air Canada either. However, the government has also been in talks for some sort of stimulus relief for airlines as well.

Now, with a COVID-19 vaccine on the horizon, things could be looking up for Air Canada. This TSX stock would stand to benefit greatly from a more active and open economy.

It’s clear the stock market has hope for Air Canada, as it’s up 24.40% today as of this writing. That’s a massive bump and is directly related to Pfizer’s big announcement.

Of course, a full-fledged recovery could take a fair amount of time and require more good news. However, TSX investors looking for a rebounding stock definitely won’t want to miss Air Canada’s liftoff.

COVID-19 vaccine possibly ahead

With Pfizer’s major breakthrough announced today, there is serious hope for an imminent COVID-19 vaccine. This is fantastic news for everyone’s safety and well-being.

For Canadian investors, it also means stock rebounds could be on the way. Enbridge and Air Canada are just two stocks due for a recovery — and a healthy economy can help facilitate that.

These investors should be sure to keep an eye on these two stocks and other top TSX gainers going forward.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Jared Seguin has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Enbridge.

More on Investing

Senior Couple Walking With Pet Bulldog In Countryside
Dividend Stocks

CPP Insights: The Average Benefit at Age 60 in 2024

The average CPP benefit at age 60 in average is low, but claiming early has many advantages with the right…

Read more »

edit Sale sign, value, discount
Investing

2 Bargains I’d Buy as They Dip Toward 52-Week Lows

Spin Master (TSX:TOY) stock and another underrated Canadian play could surge again as they look to reverse course.

Read more »

thinking
Dividend Stocks

Why Did goeasy Stock Jump 6% This Week?

The spring budget came in from our federal government, and goeasy stock (TSX:GSY) investors were incredibly pleased by the results.

Read more »

woman analyze data
Dividend Stocks

My Top 5 Dividend Stocks for Passive-Income Investors to Buy in April 2024

These five TSX dividend stocks can help you create a passive stream of dividend income for life. Let's see why.

Read more »

investment research
Stocks for Beginners

New Investors: 5 Top Canadian Stocks for 2024

Here are five Canadian stocks that might be ideal for a beginner investment portfolio.

Read more »

Pipeline
Energy Stocks

Here Is Why Enbridge Is a No-Brainer Dividend Stock

For investors looking for a no-brainer dividend stock worth holding for the long term, here's why Enbridge (TSX:ENB) should be…

Read more »

Dots over the earth connecting the world
Tech Stocks

Hot Takeaway: Concentration in 1 Stock Can Be Just Fine

Concentration in one stock can be alright under the right circumstances, and far better than buying a bunch of poor-performing…

Read more »

grow money, wealth build
Bank Stocks

TD Bank Stock Got Upgraded, and It’s a Good Time to Load Up

TD Bank (TSX:TD) stock is getting too cheap, even for analysts at the competing banks!

Read more »